Eirini Vasarmidi

Irakleion, ESYE43 71500, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Navigating the Complexity of PH-ILD: From Molecular Mechanisms to Integrated Clinical Evaluation.

Navigating the Complexity of PH-ILD: From Molecular Mechanisms to Integrated Clinical Evaluation.

Journal: International journal of molecular sciences

Published: June 29, 2026

Design of the MERCURION-IPF trial - intravenous immunoglobulin for the treatment of acute exacerbations of idiopathic pulmonary fibrosis.

Design of the MERCURION-IPF trial - intravenous immunoglobulin for the treatment of acute exacerbations of idiopathic pulmonary fibrosis.

Journal: Frontiers in immunology

Published: December 29, 2025

BALF gene expression profiling reveals a fibrosis associated innate immune activation bias in persistent post-COVID-19 ILD.

BALF gene expression profiling reveals a fibrosis associated innate immune activation bias in persistent post-COVID-19 ILD.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: November 14, 2025

Editorial: Pulmonary involvement in systemic autoimmune rheumatic diseases (SARDs): from diagnostic tools to therapeutic strategies.

Editorial: Pulmonary involvement in systemic autoimmune rheumatic diseases (SARDs): from diagnostic tools to therapeutic strategies.

Journal: Frontiers in medicine

Published: October 08, 2025

Application of the Idiopathic Pulmonary Fibrosis Patient-Reported Outcome Measure (IPF-PROM) scale to a Greek IPF patient population and its interrelation with depressive symptoms and health-related quality of life.

Application of the Idiopathic Pulmonary Fibrosis Patient-Reported Outcome Measure (IPF-PROM) scale to a Greek IPF patient population and its interrelation with depressive symptoms and health-related quality of life.

Journal: BMJ open respiratory research

Published: May 21, 2025

Insights into interstitial lung disease pathogenesis.

Insights into interstitial lung disease pathogenesis.

Journal: Breathe (Sheffield, England)

Published: December 07, 2024

FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis.

FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis.

Journal: American journal of respiratory and critical care medicine

Published: December 05, 2024

Identification of FGFR4 as a regulator of myofibroblast differentiation in pulmonary fibrosis.

Identification of FGFR4 as a regulator of myofibroblast differentiation in pulmonary fibrosis.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: October 01, 2024

Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter Study.

Performance of Lung Ultrasound as a Screening Tool for Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter Study.

Journal: Chest

Published: August 02, 2024

KL‑6, ET‑1 and S100A9 levels in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea.

KL‑6, ET‑1 and S100A9 levels in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea.

Journal: Experimental and therapeutic medicine

Published: February 23, 2024

Two women with unexplained dyspnoea: removing the blame game from the lungs.

Two women with unexplained dyspnoea: removing the blame game from the lungs.

Journal: Breathe (Sheffield, England)

Published: January 18, 2024

Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease.

Reversibility of the Enlargement of the Pulmonary Artery in COVID-19 Pneumonia as a Marker of Remission of the Disease.

Journal: Journal of personalized medicine

Published: January 15, 2024

Showing 1-12 of 45

Last Updated: 09/26/2026